Dk. Arya, IS THE 5-HYDROXYTRYPTAMINE (5-HT) NEUROTRANSMITTER SYSTEM INVOLVED INREGULATION OF EXTRAPYRAMIDAL SYMPTOMS, Journal of drug development and clinical practice, 7(4), 1996, pp. 257-267
Extrapyramidal symptoms (EPS) are thought to result from dopamine (DA)
receptor blockade, but the serotonin (5-hydroxytryptamine; 5-HT) neur
otransmitter system may also be involved. A Medline literature search
was carried out followed by a cross reference search for those article
s suggesting an interaction between dopaminergic and serotoninergic ne
urotransmitter systems and EPS. This review suggests that 'atypical' a
ntipsychotic drugs with 5-HT antagonistic properties possess higher th
erapeutic efficacy together with reduced liability to induce EPS than
typical antipsychotics. 5-HT reuptake inhibitors have also been report
ed to produce EPS and the evidence from pre-clinical and clinical stud
ies are suggestive of an interaction between 5-HT and DA neurotransmit
ter systems. The result of this literature review suggests that it is
possible that the 5-HT neurotransmitter system may regulate EPS by inf
luencing the DA neurotransmitter system.